United Biomedical, Inc., a bio/pharmaceutical company, engages in the discovery and development of immunotherapeutics and vaccines for chronic and infectious diseases. It offers human immunodiagnostics kits for detection of SARS corona viruses, human immunodeficiency viruses, hepatitis C viruses, and foot and mouth disease viruses, as well as antibodies against human T lymphotropic viruses; human immunotherapeutic and vaccines for Alzheimerâs disease, allergies, prostate cancer, and human immunodeficiency viruses; herbal medicines and nutraceuticals; and animal immunodiagnostics and animal immunotherapeutic and vaccines. The company also provides synthetic peptide-based functional antigens, which are used in immunotherapeutics and vaccines for prevention and treatment of infectious diseases and other immune disorders in capsules, tablets, creams, ointments, oral liquids, suspension, and sterile injectables formulations. In addition, it offers pharmaceutical, biologics, and peptide manufacturing services, as well as therapeutic monoclonal antibodies, recombinant proteins, and synthetic peptides
